Published: Dec 04, 2020, 04:45 IST | Updated: Dec 04, 2020, 04:45 IST
Researchers at the National Institute for Allergies and Infectious Diseases which co-developed the drug, studied the immune response of 34 adult participants, young and old, from the first stage of a clinical trial.